Skip to main content
2023 IKCS: North America Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Track: Industry Sponsored Session

Track: CME Session

Leveling Up Our RCC Care Strategy: Real-World Translation of Key Evidence Across Treatment Settings: CME/MOC/AAPA activity presented by PeerView

Friday, November 10, 2023
6:45 PM – 8:15 PM CST
Location: Music Row 5




    • This CME/MOC/AAPA activity is provided by PVI, PeerView Institute for Medical Education.
    • This educational activity is supported through medical education grants from AVEO Pharmaceuticals, Inc., Bristol Myers Squibb, and Exelixis, Inc.
    • PeerView.com/Nashville23-Live

    Reasons to Attend


  • Get expert insight on which patients with RCC may benefit from approved and emerging treatments based on the latest evidence

  • Hone your ability to develop personalized treatment strategies for patients with RCC

  • Learn how to mitigate adverse events and keep your patients receiving optimal care

    • Learning Objectives:

    • Summarize evidence on efficacy and safety of approved and emerging treatment options for patients with RCC across disease stages and histologic subtypes
    • Develop personalized therapeutic strategies based on current evidence and patient-, disease-, and treatment-specific factors for patients with RCC
    • Incorporate approaches to anticipate, mitigate, and manage adverse events associated with treatments for patients with RCC